台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238);;a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227);;b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26);;b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) - 滅菌懸液注射劑 - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) (8012002540) ug ha; b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) (8012006210) ug ha; b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26) (8012006270) ug ha; a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) (8012018070) ug ha - influenza, inactivated, split virus or surface antigen - fluarix tetra是一種四價流感疫苗，適用於成人及6個月大以上之兒童的主動免疫接種，藉以預防此疫苗所涵蓋之a型與b型流感病毒所引起的流感相關疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

瑞士商愛爾康大藥廠股份有限公司台灣分公司 新北市新店區寶中路119號4樓、5樓 (20916488) - zoledronic acid monohydrate - 注射劑 - zoledronic acid monohydrate (6400001630) (eq. to zoledronic acid anhydrous 4mg)mg - zoledronic acid - 1.與標準癌症治療併用，適用於多發性骨髓瘤及固體腫瘤併有骨骼轉移之病人。用於攝護腺癌病人之骨骼轉移時，應至少接受過一種荷爾蒙治療而仍持續惡化者。2.治療惡性腫瘤之高血鈣併發症(hcm)。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

瑞士商愛爾康大藥廠股份有限公司台灣分公司 新北市新店區寶中路119號4樓、5樓 (20916488) - zoledronic acid monohydrate - 注射劑 - zoledronic acid monohydrate (6400001630) (eq. to zoledronic acid anhydrous 4mg)mg - zoledronic acid - 1.與標準癌症治療併用，適用於多發性骨髓瘤及固體腫瘤併有骨骼轉移之病人。用於攝護腺癌病人之骨骼轉移時，應至少接受過一種荷爾蒙治療而仍持續惡化者。2.治療惡性腫瘤之高血鈣併發症（hcm）。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣諾華股份有限公司 臺北市中山區民生東路3段2號8樓 (01516589) - tisagenlecleucel (ctl019 cells) - 注射劑 - tisagenlecleucel (ctl019 cells) (1000000500) 1.2 x 10^6 to 6.0 x 10^8 car-positive viable t cellsq.s. - tisagenlecleucel - 經過基因修飾的自體免疫細胞療法，適用於治療：•患有難治型、移植後復發、第二次或二次以上復發之b細胞急性淋巴性白血病（all）的25歲以下兒童和年輕成人病人。•經兩線或兩線以上全身治療後之復發性或難治性瀰漫性大b細胞淋巴瘤（dlbcl）的成人病人。•經兩線或兩線以上全身治療後之復發性或難治性濾泡性淋巴瘤（fl）成人病人。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

國光生物科技股份有限公司 台中市潭子區潭興路一段三號 (33259508) - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238);;a/darwin/9/2021 (h3n2)-like virus (a/darwin/9/2021, san-010);;b/austria/1359417/2021-like virus (b/austria/1359417/2021,bvr-26);;b/phuket/3073/2013-like virus (b/phuket/3073/2013, bvr-1b) - 注射液劑 - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) (8012002540) a/michigan/45/2015 (h1n1)pdm09-like virusug; b/phuket/3073/2013-like virus (b/phuket/3073/2013, bvr-1b) (8012006231) b/phuket/3073/2013-like virusug; b/austria/1359417/2021-like virus (b/austria/1359417/2021,bvr-26) (8012006280) b/colorado/06/2017-like virusug; a/darwin/9/2021 (h3n2)-like virus (a/darwin/9/2021, san-010) (8012018080) a/singapore/infimh-16-0019/2016 (h3n2)-like virusug - influenza, inactivated, split virus or surface antigen - 預防流感。說明：本疫苗適用於3歲以上兒童及成人之主動免疫接種，藉以預防此疫苗所涵蓋之兩種a型及兩種b型流感病毒所引起之流感相關疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣東洋藥品工業股份有限公司 臺北市南港區園區街3之1號3樓 (11821341) - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238);;a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227);;b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26);;b/phuket/3073/2013-like virus (b/phuket/3073/2013, bvr-1b) - 滅菌懸液注射劑 - 主成分 (composition of fluad tetra suspension for injection for nh2021/2022 influenza season (quantity per dose)) ; a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) (8012002540) ug ha; b/phuket/3073/2013-like virus (b/phuket/3073/2013, bvr-1b) (8012006231) ug ha; b/austria/1359417/2021 - like strain (b/austria/1359417/2021, bvr-26) (8012006270) ug ha; a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) (8012018070) ug ha - influenza, inactivated, split virus or surface antigen - 適用於65歲以上成人之主動免疫接種，預防此疫苗所涵蓋之兩種a型及兩種b型流感病毒所引起的流行性感冒。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238);;a/darwin/9/2021 (h3n2) - like strain (a/darwin/9/2021, ivr-228);;b/austria/1359417/2021 - like strain (b/michigan/01/2021, wild type);;b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) - 無菌懸浮注射液 - a/victoria/4897/2022 (h1n1)pdm09-like strain (a/victoria/4897/2022, ivr-238) (8012002540) ug ha; b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) (8012006210) ug ha; b/austria/1359417/2021 - like strain (b/michigan/01/2021, wild type) (8012006260) ug ha; a/darwin/9/2021 (h3n2) - like strain (a/darwin/9/2021, ivr-228) (8012018060) ug ha - influenza, inactivated, split virus or surface antigen - vaxigriptetra適用於成人及6個月(含)以上兒童之主動免疫接種，預防此疫苗所涵蓋之兩種a型及兩種b型流感病毒所引起的流感相關疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣東洋藥品工業股份有限公司 台北市南港區園區街3之1號3樓 (11821341) - a/wisconsin/67/2022 (h1n1) pdm09 - like virus (a/georgia/12/2022 cvr-167);;a/darwin/6/2021 (h3n2) - like virus (a/darwin/11/2021);;b/austria/1359417/2021 - like virus (b/singapore/wuh4618/2021);;b/singapore/inftt-16-0610/2016 (a b/phuket/3073/2013-like virus) - 懸浮注射劑 - 主成分 (composition of flucelvax quad for nh2019/2020 influenza season (quantity per dose)) ; b/singapore/inftt-16-0610/2016 (a b/phuket/3073/2013-like virus) (8012002484) ug ha; b/austria/1359417/2021 - like virus (b/singapore/wuh4618/2021) (8012006285) ug ha; a/wisconsin/67/2022 (h1n1) pdm09 - like virus (a/georgia/12/2022 cvr-167) (8012018042) ug ha; a/darwin/6/2021 (h3n2) - like virus (a/darwin/11/2021) (8012018051) ug ha - influenza, inactivated, split virus or surface antigen - 適用於6個月以上兒童及成人之主動免疫接種，預防此疫苗所涵蓋之兩種a型及兩種b型流感病毒所引起的流感相關疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - l-isoleucine;;l-leucine;;l-lysine acetate;;l-methionine;;acetylcysteine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;arginine;;l-histidine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-alanine;;l-proline;;l-serine - 注射劑 - l-alanine (4020100202) 4.64mg; arginine (4020100300) 10.72mg; l-histidine (4020100902) 2.8mg; l-isoleucine (4020101002) 10.4mg; l-leucine (4020101202) 13.09mg; l-lysine acetate (4020101322) 9.71mg; l-methionine (4020101502) 1.10mg; l-phenylalanine (4020101702) 0.88mg; l-proline (4020101802) 5.73mg; l-serine (4020101902) 2.24mg; l-threonine (4020102002) 4.40mg; l-tryptophan (4020102102) 0.70mg; l-valine (4020102302) 10.08mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 5.82mg; acetylcysteine (4800000100) 0.70mg - amino acids - 腸外營養補充劑

中国 - 中文 - CFDA (药监局 - 中国食品和药物管理局)

fresenius kabi austria gmbh - 口服溶液剂 - 15ml:10g